Abano Healthcare Group Limited provided earnings guidance for the first six months ended November 30, 2012. The company is expecting revenues of between $105.4 million to $107.4, an EBITDA of between $13.6 million to $14.6 million and a NPAT to be in the range of $1.3 million to $1.8 million. The underlying earnings are expected to be an EBITDA of between $14.1 million to $15.1 million and a NPAT of between $2.1 million to $2.6 million.